# TransCode Therapeutics, Inc. (RNAZ) - Q4 2024 earnings

Reported March 28, 2025.

| | Reported | Consensus estimate |
| --- | --- | --- |
| Revenue | Not available | $300.0K |
| EPS | $-16.61 | $-105.93 |

Earnings filing reader: [8-K 0001104659-25-027565](https://www.opencapital.sh/filings/0001104659-25-027565)
Agent-readable filing: [Markdown](https://www.opencapital.sh/filings/0001104659-25-027565.md)
Original filing: [SEC.gov filing index](https://www.sec.gov/Archives/edgar/data/1829635/0001104659-25-027565-index.htm)
Canonical page (please cite this URL): https://www.opencapital.sh/stocks/rnaz/earnings/q4-2024